Cargando…

Drug absorption in bariatric surgery patients: A narrative review

BACKGROUND: Despite the increase in the number of bariatric surgeries performed, little is known about the impact of the surgery on drug absorption. Unpredictability is assumed with drugs, given the anatomical changes after surgery. OBJECTIVE: To evaluate the impact of bariatric surgery on drug abso...

Descripción completa

Detalles Bibliográficos
Autores principales: Alalwan, Abdullah Abdulaziz, Friedman, Jeffrey, Alfayez, Osamah, Hartzema, Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059175/
https://www.ncbi.nlm.nih.gov/pubmed/35509385
http://dx.doi.org/10.1002/hsr2.605
_version_ 1784698256980180992
author Alalwan, Abdullah Abdulaziz
Friedman, Jeffrey
Alfayez, Osamah
Hartzema, Abraham
author_facet Alalwan, Abdullah Abdulaziz
Friedman, Jeffrey
Alfayez, Osamah
Hartzema, Abraham
author_sort Alalwan, Abdullah Abdulaziz
collection PubMed
description BACKGROUND: Despite the increase in the number of bariatric surgeries performed, little is known about the impact of the surgery on drug absorption. Unpredictability is assumed with drugs, given the anatomical changes after surgery. OBJECTIVE: To evaluate the impact of bariatric surgery on drug absorption based on the type of procedure performed. METHODS: We conducted a comprehensive literature review searching PubMed/Medline for published studies (from inception to December 2017) that evaluate the use of drugs and the assessment of drug absorption after bariatric surgery. Pharmacokinetic/pharmacodynamic studies, case reports, and observational studies were included in our review. RESULTS: We found 60 studies addressing drug use after bariatric surgery. Twenty‐eight studies reported a decrease in drug absorption after bariatric surgery while only four studies showed an increase in drug absorption. Unchanged absorption of drugs was seen in 23 studies after the surgery. CONCLUSION: The available information shows variations in drug absorption after bariatric surgery. The unpredictability may result from factors related to the patient, drug, and/or type of surgery. Therefore, pharmacists' involvement and close monitoring of patients after bariatric surgery could be effective to avoid sub‐/supratherapeutic responses.
format Online
Article
Text
id pubmed-9059175
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90591752022-05-03 Drug absorption in bariatric surgery patients: A narrative review Alalwan, Abdullah Abdulaziz Friedman, Jeffrey Alfayez, Osamah Hartzema, Abraham Health Sci Rep Reviews BACKGROUND: Despite the increase in the number of bariatric surgeries performed, little is known about the impact of the surgery on drug absorption. Unpredictability is assumed with drugs, given the anatomical changes after surgery. OBJECTIVE: To evaluate the impact of bariatric surgery on drug absorption based on the type of procedure performed. METHODS: We conducted a comprehensive literature review searching PubMed/Medline for published studies (from inception to December 2017) that evaluate the use of drugs and the assessment of drug absorption after bariatric surgery. Pharmacokinetic/pharmacodynamic studies, case reports, and observational studies were included in our review. RESULTS: We found 60 studies addressing drug use after bariatric surgery. Twenty‐eight studies reported a decrease in drug absorption after bariatric surgery while only four studies showed an increase in drug absorption. Unchanged absorption of drugs was seen in 23 studies after the surgery. CONCLUSION: The available information shows variations in drug absorption after bariatric surgery. The unpredictability may result from factors related to the patient, drug, and/or type of surgery. Therefore, pharmacists' involvement and close monitoring of patients after bariatric surgery could be effective to avoid sub‐/supratherapeutic responses. John Wiley and Sons Inc. 2022-04-26 /pmc/articles/PMC9059175/ /pubmed/35509385 http://dx.doi.org/10.1002/hsr2.605 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Reviews
Alalwan, Abdullah Abdulaziz
Friedman, Jeffrey
Alfayez, Osamah
Hartzema, Abraham
Drug absorption in bariatric surgery patients: A narrative review
title Drug absorption in bariatric surgery patients: A narrative review
title_full Drug absorption in bariatric surgery patients: A narrative review
title_fullStr Drug absorption in bariatric surgery patients: A narrative review
title_full_unstemmed Drug absorption in bariatric surgery patients: A narrative review
title_short Drug absorption in bariatric surgery patients: A narrative review
title_sort drug absorption in bariatric surgery patients: a narrative review
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059175/
https://www.ncbi.nlm.nih.gov/pubmed/35509385
http://dx.doi.org/10.1002/hsr2.605
work_keys_str_mv AT alalwanabdullahabdulaziz drugabsorptioninbariatricsurgerypatientsanarrativereview
AT friedmanjeffrey drugabsorptioninbariatricsurgerypatientsanarrativereview
AT alfayezosamah drugabsorptioninbariatricsurgerypatientsanarrativereview
AT hartzemaabraham drugabsorptioninbariatricsurgerypatientsanarrativereview